Photodynamic therapy of 9L gliosarcoma with liposome-delivered photofrin

Photochemistry and Photobiology

Volumn 65, Issue 4, 1997, Pages 701-706

  Jiang, Feng ^a   Lilge, Lothar ^b   Logie, Bradley ^a   Li, Yi ^a   Chopp, Michael ^a,c,d  

^a HENRY FORD HEALTH SCIENCES CENTER   (United States)

^b Photonics Research Ontario   (Canada)

^c OAKLAND UNIVERSITY   (United States)

^d HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031128047     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-1097.1997.tb01913.x     Document Type: Article

References (40)

1. Origitano, T. C., M. J. Caron and O. H. Reichman (1994) Photodynamic therapy for intracranial neoplasms. Mol. Chem. Neuropathol. 21, 337-352.
2. Horne, R. W., A. D. Bangham and V. P. Whittaker (1963) Negatively stained lipoprotein membranes. Nature 200, 1340.
3. Treat, J., A. R. Greenspan and A. Rahman (1989) Liposome encapsulated doxorubicin: preliminary results of phase I and phase II trials. In Liposomes in the Therapy of Infectious Diseases and Cancer (Edited by G. Lopez-Berestein and I. J. Fidler), pp. 353-365. Alan R. Liss, New York.
4. Alving, C. R., R. L. Richards, J. Moss, L. I. Alving, J. D. Clements, T. Shiba, S. Kotani, R. A. Wirtz and W. T. Hockmeyer (1986) Effectiveness of liposomes as potential carriers of vaccines: applications to cholera toxin and human malaria sporozoite antigen. Vaccine 4, 166-172.
5. Allison, A. G. and G. Gregoriadis (1974) Liposomes as immunological adjuvants. Nature 252, 252.
6. Jori, G., L. Tomio, E. Reddi, L. Corti, P. L. Zorat and F. Calzavara (1983) Preferential delivery of liposome-incorporated porphyrins to neoplastic cells in tumour-bearing rats. Br. J. Cancer 48, 307-309.
7. Chopp M., M. O. Dereski, L. Madigan, F. Jiang, B. Logic (1996) Sensitivity of 9L gliosarcomas to photodynamic therapy. Rad. Res. 146, 461-465.
8. Dereski, M. O., M. Chopp, J. H. Garcia and F. W. Hetzel (1991) Depth measurements and histopathological characterization of PDT generated normal brain necrosis as a function of incident optical energy dose. Photochem. Photobiol. 54, 109-112.
9. Lilge, L., C. O'Carroll and B. C. Wilson (1997) A solubilization technique for photosensitizer quantification in ex vivo tissue samples. J. Photochem. Photobiol. (In press)
10. Milanesi, C., F. Sorgato and G. Jori (1989) Photokinetic and ultrastructural studies on porphyrin photosensitization of HeLa cells. Int. J. Radiat. Biol. 55, 59-60.
11. Jori, G., E. Reddi, I. Cozzani and L. Tomio (1986) Controlled targeting of different subcellular sites by porphyrins in tumour-bearing mice. Br. J. Cancer 53, 615-621.
12. Hasegawa, H., Y. Ushio, T. Hayakawa, K. Yamada and H. Mogami (1983) Changes of the blood - brain barrier in experimental metastatic brain tumor. J. Neurosurg. 59, 304-310.
13. Yamada, K., Y. Ushio, T. Hayakawa, A. Kato, N. Yamada and H. Mogami (1982) Quantitative autoradiographic measurements of blood - brain barrier permeability in the rat glioma model. J. Neurosurg. 57, 394-398.
14. Ji, Y., D. L. Walstad, J. T. Brown and S. K. Powers (1992) Relation between polyporphyrin distribution and blood brain barrier changes in the rat glioma model. Lasers Surg. Med. 12, 174-179.
15. Kessel, D., P. Thompson, K. Saatio and D. Nantwi (1987) Tumour localization and photosensitization by sulfonated derivatives of tetraphenylporphine. Photochem. Photobiol. 45, 787-790.
16. Jori, G. and E. Reddi (1990) Strategies for tumor targeting by photodynamic sensitizers. In Photodynamic Therapy of Neoplastic Disease (Edited by D. Kessel), pp. 117-130. CRC Press, Boca Raton, FL.
17. Kongshaug, M., J. Moan, L. S. Cheng, G. M. Garbo, S. Kolboe, A. R. Morgan and C. Rimington (1983) Binding of drugs to human plasma proteins, exemplified by Sn(IV)-etiopurpurin dichloride delivered in cremaphor and DMSO. Int. J. Biochem. 25, 739-760.
18. Reddi, E., G. Lo Castro, R. Biolo and G. Jori (1987) Pharmacokinetic studies with zinc(II)-phthalocyanine in tumour-bearing mice. Br. J. Cancer 56, 597-600.
19. Polo, L., E. Reddi, G. M. Garbo, A. R. Morgan and G. Jori (1992) The distribution of the tumour photosensitizers Zn(II)-phthalocyanine and Sn(IV)-etiopurpurin among rabbit plasma proteins. Cancer Lett. 66, 217-223.
20. Allison, B. A., P. H. Pritchard, A. M. Richter and J. G. Levy (1990) The plasma distribution of benzoporphyrin derivative and the effects of plasma lipoproteins on its biodistribution. Photochem. Photobiol. 52, 501-507.
21. Kessel, D. (1986) Porphyrin - lipoprotein association as a factor in porphyrin localization. Cancer Lett. 33, 183-188.
22. Jori, G. and E. Reddi (1993) The role of lipoproteins in the delivery of tumour-targeting photosensitizers. Int. J. Biochem. 25, 1369-1375.
23. Peng, Q., J. Moan, G. Garrants, H. E. Danielsen and C. Rimington (1990) Localization of potent photosensitizers in human tumor LOX by means of laser scanning microscopy. Cancer Lett. 53, 129-139.
24. Zhou, C. (1989) Mechanisms of tumor necrosis induced by photodynamic therapy. J. Photochem. Photobiol. B Biol. 3, 299-318.
25. Love, W. G., S. Duk, R. Biolo, G. Jori and P.W. Taylor (1996) Liposome-mediated delivery of photosensitizers: localization of zinc (II)-phthalocyanine within implanted tumors after intravenous administration. Photochem. Photobiol. 63, 656-661.
26. Cuomo, V., G. Jori, B. Rihter, M. E. Kenney and M. A. J. Rodgers (1990) Liposome-delivered Si(IV)-naphthalocyanine as a photodynamic sensitizer for experimental tumours: pharmacokinetic and physiotherapeutic studies. Br. J. Cancer 62, 966-970.
27. Ginevra, F., S. Biffanti, A. Pagnan, R. Biolo, E. Reddi and G. Jori (1990) Delivery of the tumour photosensitizer zinc(II)-phthalocyanine to serum proteins by different liposomes: studies in vitro and in vivo. Cancer Lett. 49, 59-65.
28. Richter, A. M., E. Waterfield, A. K. Jain, A. J. Canaan, B. A. Allison and J. G. Levy (1993) Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), to tumor tissue in a mouse tumor model. Photochem. Photobiol. 57, 1000-1006.
29. Valduga, G., E. Reddi, G. Jori, R. Cubeddu, P. Taroni and G. Valentini (1992) Steady state and time-resolved spectroscopic studies on zinc(II) phthalocyanine in liposomes. J. Photochem. Photobiol. B Biol. 16, 331-340.
30. Shopova, M., V. Mantareva, K. Krastev, D. Hadjiolov, A. Milev, K. Spirov, G. Jori and F. Ricchelli (1992) Comparative pharmacokinetic and photodynamic studies with zinc(II) phthalocyanine in hamsters bearing an induced or transplanted rhabdomyosarcoma. J. Photochem. Photobiol. B Biol. 16, 83-89.
31. Bertolone, G., F. Rossi, G. Valduga, G. Jori, H. Ali and J. E. van Lier (1992) Photosensitizing activity of water-and lipid soluble phthalocyanines on prokaryotic and eukaryotic microbial cells. Microbios 71, 33-46.
32. Gabizon, A. A. (1994) Liposomal anthracyclines. New Drug Ther. 8, 431-150.
33. Woodle, M. C. and D. D. Lasic (1992) Sterically stabilized liposomes. Biochim. Biophys. Acta 1113, 171-191.
34. Hoebeke, M. (1995) The importance of liposomes as models and tools in the understanding of photosensitization mechanisms. J. Photochem. Photobiol. B Biol. 28, 189-196.
35. Doi, K., N. Oku, T. Toyota, S. Shuto, A. Sakai, H. Itoh and S. Okada (1994) Therapeutic effect of reticuloendothelial system (RES) - avoiding liposomes containing a phospholipid analogue of 5-fluorouracil, dipalmitoylphosphatidylfluorouridine, in Meth A sarcoma-bearing mice. Biol. Pharm. Bull. 17, 1414-1416.
36. Garbo, G. M. and A. R. Morgan (1988) Delivery systems for Hydrophobic drugs. J. Photochem. Photobiol. B Biol. 1, 494-495.
37. Jori, G. (1990) Photosensitized processes in vivo: proposed phototherapeutic applications. Photochem. Photobiol. 52, 439-443.
38. Gabizon, A., D. Goren, Z. Fuks, A. Meshorer and Y. Barenholz (1985) Superior therapeutic activity of liposomal-associated adriamycin in a murine metastatic tumor model. Br. J. Cancer 51, 681-689.
39. Murray, J. L., E. S. Kleinerman, J. R. Tatom, J. E. Cunningham, J. Lepe-Zuniga, J. U. Gutterman, K. Andrejcio, I. J. Fidler and I. H. Krakoff (1989) A pilot phase I trial of liposomal N-acetylmuramyl-L-alanyl-D-isoglutaminyl-L-alanylphosphatidylethanolamine [MTP-PE (CGP 19835A)] in cancer patients. In Liposomes in the Therapy of Infectious Diseases and Cancer (Edited by G. Lopez-Berestein and I. J. Fidler), pp. 329-342. Alan R. Liss, New York.
40. Parnham, M. J. and H. Wetzig (1993) Toxicity screening of liposomes. Chem. Phys. Lipids 64, 263-274.